Condition
Coronary Ischemia
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Completed2
Suspended1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03383393UnknownPrimary
Pharmacologic Treatment of Myocardial Ischemia Detected by Intracoronary ECG
NCT00790764Phase 2Suspended
Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI)
NCT01356836Completed
The Association Between Different Monocyte Subsets and Coronary Collateral Development
NCT00643981Phase 1CompletedPrimary
Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia
Showing all 4 trials